tbuckley/cabot-search huggingface dataset:
Risk calculations for HIV transmission from infected health care workers
Authors: R. K. St John
Journal: JAMA (1993)

<h3>To the Editor.</h3> —Von Reyn et al<sup>1</sup>have underestimated the upper limit of the 95% CI (0 to 4.37/100 000 patients). The conclusions of von Reyn et al minimize the risk. Nevertheless, the finding of 0% prevalence among patients recalled and tested in their article and in the companion articles<sup>2,3</sup>is reassuring. Based an the binomial model, when testing a sample representing 50.7% of the study population (1174 tested of 2317 potentially exposed patients), the chance that there is one positive individual who is not included in the sample is high (50.2%). This probability is precisely calculated by the following: (1-1/n)<sup>0.507n</sup>, where<i>n</i>is the population size (2317). If one HIV-infected patient was missed, then the sero-prevalence in this population would be 4.3 per 10 000 patients (1/2317), or 10-fold higher than the 95% upper CI of von Reyn et al. At the critical 0.05 confidence level,
Correction of Units of Measure in a Table and the Text
Authors: Robert Clarke, Theingi Aung, Jane Armitage
Journal: JAMA Cardiology (2018)

going primary coronary angioplasty was associated with a lower risk of subsequent myocardial infarction or death from all causes, but such nonrandomized comparisons cannot exclude the effects of bias or confounding by other risk factors.The lower 95% CI used in the Omega-3 Treatment Trialists' Collaboration meta-analysis 1 indicates that the metaanalysis cannot exclude a 7% lower risk of major vascular events or 10% lower risk of any CHD event.Importantly, the meta-analysis demonstrated no difference in the effects of ω-3 fatty acids on major vascular events in any of the subgroups studied. 1 In particular, there were no differences in the effects of ω-3 fatty acids in those with or without a history of prior vascular disease.
The Propaganda for Reform
Journal: JAMA (1923)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
PORTUGAL
Journal: JAMA (1960)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Abstract 007: Nonalcoholic Fatty Liver Disease and Subclinical Atherosclerosis: Analyses from the Coronary Artery Risk Development in Young Adults (CARDIA) Study
Authors: Lisa B VanWagner, Christina M Shay, Hongyan Ning, John Wilkins, Cora E Lewis, Jeff Carr, James G Terry, Donald Lloyd-Jones, David Jacobs, Mercedes Carnethon
Journal: Circulation (2013)

Background: Nonalcoholic Fatty Liver Disease (NAFLD) and excess visceral adipose tissue (VAT) are associated with cardiovascular disease (CVD). Recent studies suggest that NAFLD and coronary artery calcification (CAC) are related independent of VAT. In a population-based cross-sectional sample of black and white adults free from prevalent liver or heart disease, we tested the hypothesis that NAFLD is associated with the presence of CAC and abdominal aortoiliac calcification (AAC) independent of VAT and other CVD risk factors. Methods: Participants from the Coronary Artery Risk Development in Young Adults study (Y25 exam) with concurrent computed tomography quantification of liver fat, CAC and AAC were included (n=2,163). NAFLD was defined as liver attenuation ≤ 40 Hounsfield Units after exclusion of other causes of liver fat (medication/alcohol use). Using the Agatston method, CAC/AAC presence was defined as a score &gt; 0. Logistic regression models were used to calculate odds ratios and 95% confidence intervals. Results: Participant age was 49.9 (3.7) years and the sample was equally distributed by sex (55.6% female) and race (50.1% black). Mean BMI was 30.6 (7.1). The CAC and AAC prevalence was 26.5% and 49.6%. NAFLD prevalence was 9.6%. NAFLD participants were 50.1 (3.7) years old and more likely to be male (59.8% vs. 51.7%, p&lt;0.0001), white (56.5% vs. 49.3%, p&lt;0.05) and have the metabolic syndrome (70.1% vs. 22.6%, p&lt;0.0001) than those with no NAFLD. They were also more likely to have CAC (37.2%) and AAC (60.9%) than those with no NAFLD (25.4% and 49.4%, respectively). In multivariable analyses adjusted for demographics and health behaviors, NAFLD was associated with the presence of CAC and AAC (Table 1). This association was attenuated after adjustment for CVD risk factors and VAT. Effect modification by race and sex was not statistically significant. Conclusion: In contrast to prior studies, our results suggest that the relationship between NAFLD and subclinical CVD is mediated by the presence of other CVD risk factors.
Physician-competitor's advice to colleagues: steroid users respond to education, rehabilitation
Authors: V. Cowart
Journal: JAMA (1987)

IN THE SPRING of 1976, Craig Brigham was headed for the Olympic track and field trials with the second highest score (after Bruce Jenner) in the decathlon. His Olympic hopes were dashed when, almost on the eve of the trials, he contracted mononucleosis. Although he competed, he placed 13th in the standings, and did not make the 1976 Olympic team. Brigham, who set a high school decathlon record in Oregon that still stands, now lives in Chicago where he is finishing a residency in orthopedic surgery at Northwestern University. As a world-class athlete and now as a physician, he has a particular perspective on the anabolic steroid issue. (Please see accompanying article.) "People generally have no conception of what it takes to be an Olympic champion," Brigham says. "I can't speak for all athletes, but I do realize it's a full-time job and that the competition is with athletes who
Reply
Authors: F. Caux
Journal: British Journal of Dermatology (1995)

Journal Article Reply Get access F. Caux F. Caux Clinique des Maladies Cutanées, Hôpital Saint Louis, 1 Avenue Claude Vellefaux, 75010 Paris, France Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 132, Issue 3, 1 March 1995, Page 488, https://doi.org/10.1111/j.1365-2133.1995.tb08697.x Published: 01 March 1995
Hereditary Factors in Human Leukemia: A Report of Four Cases of Leukemia in a Family
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
PAPULAR URTICARIA*
Authors: RUPERT HALLAM
Journal: British Journal of Dermatology (1927)

Journal Article PAPULAR URTICARIA Get access RUPERT HALLAM, M.D., Ch.B. RUPERT HALLAM, M.D., Ch.B. Honorary Dermatologist, Royal Infirmary, Sheffield Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology and Syphilis, Volume 39, Issue 3, 1 March 1927, Pages 95–111, https://doi.org/10.1111/j.1365-2133.1927.tb10054.x Published: 01 March 1927
Lymphoma neoantigens
Authors: Joshua E. Elias
Journal: HemaSphere (2018)

Stanford University, Stanford, CA, USA This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CCBY-NC-ND), which allows third parties to download the abstracts and share them with others as long as they credit the author and the abstract book, but they cannot change the content in any way or use them commercially. http://creativecommons.org/licenses/by-nc-nd/4.0
New Names
Journal: JAMA (1973)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
PSA response and early PSA progression evaluated in patients randomized in a phase III trial comparing androgen deprivation therapy (ADT) plus docetaxel versus ADT alone in hormone-naive metastatic prostate cancer (GETUG-AFU 15/0403).
Authors: G. Gravis, K. Fizazi, F. Joly, S. Oudard, F. Priou, I. Latorzeff, R. Delva, B. Esterni, M. Habibian, M. Soulie
Journal: Journal of Clinical Oncology (2011)

4524 Background: Androgen deprivation therapy (ADT) is the standard treatment of hormone naïve metastatic prostate cancer (HNMPC). We initiated a phase III multicentre trial comparing ADT with or without docetaxel (D) in HNMPC (GETUG 15) and the primary endpoint is overall survival. PSA progression defined as an increase of 25% over baseline or nadirin the first 7 months was recently shown to be a strong predictor of death in HNMPC (Hussain M et al J Clin Oncol 27: 2009). Methods: Patients (pts) with HNMPC were randomly assigned to either arm A (ADT plus D: 75mg/m² q3w, 9 cycles) or arm B (ADT). From 10/2004 to 12/2008, 385 pts were accrued. The median baseline PSA values were 29.4 ng/ml (0.05-2,170) in arm A and 25.3 ng/ml (0.1-11,900) in arm B. Data on PSA response are available in 171/192 pts (arm A) pts and 181/193 pts (arm B) at 3 months and 156 pts (arm A) and 148 pts (arm B) at 6 months. Results: A PSA response (> 30%) was achieved at 3 months in 93.6% (arm A) and 85.1% (arm B) (p=0.02). A PSA response (> 50%) was achieved at 3 months in 90.6% (arm A) versus 80.1% (arm B) (p=0.01). When assessed at 6 months, a PSA response (> 30%) was obtained in 94.9% (arm A) versus 86.5% (arm B) (p=0.02). A PSA response (> 50%) was achieved in 94.9% (arm A) versus 85.8% (arm B) (p=0.01) A PSA progression ( 25% increase) was observed in 1.3% in arm A and 10.1% in arm B (p=0.002). Conclusions: The addition of 3-weekly docetaxel to ADT significantly improves PSA response and significantly reduces PSA progression at 6 months in patients with HNMPC.
LSD and chromosomes. A controlled experiment
Authors: J. H. Tjio
Journal: JAMA (1969)

The chromosomes of lymphocytes were studied in 32 patients before and after they took lysergic acid diethylamide (LSD) as part of double-blind, controlled research of the effects of the drug in psychotherapy and in five black-market LSD users who volunteered to take pure LSD in a research setting. Statistical analysis revealed no significant difference between the before- and after-LSD chromosomal aberration rates. In addition, a post-LSD study of eight normal subjects who had received LSD in previous research experiments was also performed with the same cytogenetic methods. The results of these experiments consistently supported the conclusion that at this time there is no definite evidence that pure LSD damages chromosomes of human lymphocytes in vivo as studied from 72-hour cultures.
Preventing suicide
Authors: A Warsop
Journal: BMJ (1994)

results were obtained for survival up to six months.The analysis was repeated for specific age groups: women aged 60-69 had a worse chance of survival to six months (P<003) but not to two years (P> 0075).No difference was found in either the younger or the older age groups.1.00 40-49 50-59 60-69 o .0cL 0.50 70-79 '.) 0.25 Men Women 0O O 16o 200 300 400 500 600 700 Time after infarction (days)Age specific Kaplan-Meier survival curves in men and women with acute myocardial infarction in first two years after admission to hospital (P>0 44)These Scottish data suggest that the poorer survival of women may be attributed to the different age distributions of the men and women admitted to hospital.The use of statistical methods that adjust for age across whole populations may, however, disguise differences in particular age groups' experience of disease.
Oncologists' perception of residual cancer recurrence risk and recommended follow-up care.
Authors: Arnab Basu, Rohit Gosain, Kenneth David Miller
Journal: Journal of Clinical Oncology (2015)

Article Tools Patient and Survivor Care Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/jco.2015.33.15_suppl.e20619 Journal of Clinical Oncology - published online before print May 20, 2015 Oncologists' perception of residual cancer recurrence risk and recommended follow-up care. Arnab BasuxArnab BasuSearch for articles by this author , Rohit GosainxRohit GosainSearch for articles by this author , Kenneth David MillerxKenneth David MillerSearch for articles by this author Show More Sinai Hospital of Baltimore/ Johns Hopkins University, Baltimore, MD; Sinai Hospital of Baltimore / Johns Hopkins University, Baltimore, MD; Sinai Hospital of Baltimore, Baltimore, MD Abstract Disclosures https://doi.org/10.1200/jco.2015.33.15_suppl.e20619 Abstract Abstract e20619 Background: Many medical oncologists avoid using the word "cure" even at 20 years post-diagnosis. Little data has been reported on oncologists' perceptions of patients’ residual risk of recurrence and their recommendations for follow-up care. Methods: E-mail requests were sent to oncologists to review four brief case scenarios and to indicate their perception of the patients’ residual risk of recurrence (Essentially Zero, 1-10%, 11-25%, 26-50%, 51-75%, 76-100%) and their recommended follow-up care. We also conducted a literature review to estimate actual recurrence risks for these stated scenarios. Results: 130 medical oncologists responded. The percentage who perceived a zero or essentially zero risk of recurrence steadily increased at the 5,10, 15, and 20+ year post-diagnosis time points in patients with Stage II triple negative breast, Stage II colon, Stage II lung, and Diffuse Large B-cell Lymphoma. Follow-up for 20+ years was recommended by 43%, 27%, 32%, and 38% of respondents respectively. Among respondents who recommended this long-term follow-up 37%, 63%, 57%, and 58% perceived no residual risk of recurrence after 20 years. There was no statistically significant relationship between recommending follow-up at > 20 years and the perception of the patient having a non-zero risk of recurrence. Even at twenty years post-diagnosis a > 10% risk of recurrence was expected by 14%, 8%, 10%, and 11% of respondents.However,a literature review indicated recurrence risks of < 5% after 10 years of disease free survival for patients with each described scenario. Conclusions: The risk of cancer recurrence is typically greatest in the initial years after diagnosis and then decreases, especially after 10 years. In this study, many medical oncologists still perceived a > 10% residual risk of recurrence at 10, 15, and 20 years post-diagnosis and recommended follow-up visits. © 2015 by American Society of Clinical Oncology
BCOR as a Novel Fusion Partner of Retinoic Acid Receptor Alpha In a t(X;17)(p11;q12) Variant of Acute Promyelocytic Leukemia
Authors: Yukiya Yamamoto, Sachiko Tsuzuki, Motohiro Tsuzuki, Kousuke Handa, Yoko Inaguma, Nobuhiko Emi
Journal: Blood (2010)
RADIOMETRIC MEASUREMENTS ON THE CARBON ARC AND OTHER SOURCES USED IN PHOTOTHERAPY
Authors: W. W. COBLENTZ
Journal: JAMA (1927)

In view of the interest of the subject to phototherapists, in a previous paper data were presented on the ultraviolet component radiation from the carbon and the mercury arc lamps, and from the sun. The data thus summarized<sup>1</sup>for the benefit of phototherapists foreshadowed further investigations in this domain. The present investigation was carried out in cooperation with the Research Laboratory of the National Carbon Company, which provided extensive lamp equipment and a part of the personnel. In the accompanying table is given a summary of the various samples of material examined. <h3>APPARATUS AND METHODS</h3> In the present section are given some of the essential details of the experimental procedure, and the apparatus used in this investigation in which the measurements were made in duplicate, (1) by mapping the ultraviolet spectrum by means of a quartz spectroradiometer and (2) by measuring the spectral components of the total radiation emitted
Reply
Authors: C.E.M. Griffiths, L. Fry
Journal: British Journal of Dermatology (1986)

Journal Article Reply Get access C.E.M. Griffiths, C.E.M. Griffiths Department of Dermatology, St Mary's Hospital, London W2 INY, U.K. Search for other works by this author on: Oxford Academic Google Scholar L. Fry L. Fry Department of Dermatology, St Mary's Hospital, London W2 INY, U.K. Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 114, Issue 2, 1 February 1986, Pages 266–267, https://doi.org/10.1111/j.1365-2133.1986.tb02810.x Published: 01 February 1986
Molecular Loci for Potential Drug Toxicity in Ovaries
Authors: JoAnne S. Richards
Journal: Environmental Health Perspectives (1986)

Ovarian follicular development is dependent on the actions and interactions of the pituitary gonadotropins, FSH and LH, and the ovarian steroid hormone, estradiol. Agents which might block the effects of these hormones would increase follicular atresia and reduce fertility. In addition, any substance toxic to the oocyte and its normal pattern of growth and meiosis would lead to reduced numbers of oocytes and follicles and impaired fertility. Autoimmune diseases may be one major cause of premature ovarian failure, and such diseases might be triggered by toxic external stimuli.
Psychosis
Authors: None M
Journal: JAMA (1970)

Yesterday on Valentine's day I got a heart. It came on a surgical tray all sterile and perfused and pumping from a man they said couldn't use it anymore. They put it in my chest and threw mine away because they said mine wasn't any good anymore. Tell me: Who is me? Am I the one who grows stinking under the wilted flowers that were already too old to last a two-day wake? Or am I the one who grows pickled and preserved in the jar of formalin lost in the laboratory forever? Or maybe I am really the one who is not the me I was but lives only because of another. No longer me. Nor him. Tell me: Who is me? It is essential that I know.
In the Spotlight: BioInstrumentation
Authors: K.-i. Yamakoshi
Journal: IEEE Reviews in Biomedical Engineering (2009)

In this review, four topics are briefly introduced, these are: 1) ballistocardiography revisited; 2) current studies on noninvasive measurement of arterial blood pressure; 3) electrophysiological measurement with dry electrodes; and 4) recent advances in noninvasive optical measurement of blood constituents.
PERICOLITIS
Authors: T. Carwardine
Journal: BMJ (1913)

PERICOLITIs has its simplest manifestation in the local peritonitis which accompanies the firm impaction of a faecal mass in. the colon.The bowel is congested and granular, and peritoneal exuldate surrounds the area.In lesions of the mucous membrane of the colon causing infection through the lymphatics the adjoining mesentery becomes thickened and slhortened from chronic inflammlation, a feature met with opposite the diseased area in chronic appendicitis, wlicih causes killking of thle appendix at its middle or proximal part.I'i.1.-Effecu ot -aronic inflamnmation of the mesentery of the appendix m-esoappenaicitis.';'